RETINAL MICROVASCULATURE ALTERATION IN ACTIVE THYROID-ASSOCIATED OPHTHALMOPATHY

被引:48
|
作者
Ye, Lei [1 ]
Zhou, Shuang-Shuang [2 ]
Yang, Wen-Long [3 ]
Bao, Jing [1 ]
Jiang, Nan [4 ]
Min, You-Lan [1 ]
Yuan, Qing [1 ]
Tan, Gang [2 ]
Shen, Mei [4 ]
Shao, Yi [1 ]
机构
[1] Nanchang univ, Jiangxi Prov Clin Ophthalmol Inst, Affiliated Hosp 1, Dept Ophthalmol, Nanchang, Jiangxi, Peoples R China
[2] Univ South China, Affiliated Hosp 1, Dept Ophthalmol, Hengyang, Hunan, Peoples R China
[3] Nanchang Univ, Affiliated Hosp 2, Dept Infect Dis, Nanchang, Jiangxi, Peoples R China
[4] Xiamen Univ, Fujian Prov Key Lab Ophthalmol & Visual Sci, Eye Inst, Xiamen, Fujian, Peoples R China
基金
中国国家自然科学基金;
关键词
FOVEAL AVASCULAR ZONE; VEIN BLOOD-FLOW; GRAVES OPHTHALMOPATHY; DIABETIC-RETINOPATHY; ORBITAL DECOMPRESSION; CHOROIDAL CIRCULATION; ANGIOGRAPHY; DISEASE; PATHOGENESIS; ORBITOPATHY;
D O I
10.4158/EP-2017-0229
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: It is uncertain whether there is an increased retinal vessel density in patients with thyroid-associated ophthalmology (TAO), or if ocular hemodynamic changes are associated with their vision. Many techniques have been applied to analyze ocular hemodynamic changes in TAO patients; however, they suffer from limitations. Optical coherence tomography angiography (OCTA) is more sensitive to hemodynamic changes. We performed OCTA to determine whether there is an increased retinal vessel density in TAO patients, and investigate associations with their vision. Methods: Twenty TAO patients (right eye) and 20 normal controls (right eye) were recruited for the study. Three-dimensional OCTA images were generated with 6 x 6-mm angiographic OCT scans of the superficial retinal layer (SRL) and deeper retinal layer (DRL) of the macular retina for each eye. We calculated the microvascular (MIR) and microvascular (MAR) densities and compared MIR, MAR, and total MIR (TMI) density in the healthy control and TAO groups separately. We used the annular partition (C1-C6) and quadrant partition method to analyze retinal vessel density alterations. Correlation analyses were used to examine the association of MIR density and visual acuity. Results: In the SRL, STMI (superficial TMI) and SMIR (superficial MIR) density increased in the macular area of TAO patients (P<.05). For the DRL, the density of DMIR (deeper MIR) increased in macular area only (P<.05). However, with the annular partition method, TAO patients showed significantly increased SMIR density in the C1 and C2 regions (P<.05), and increased DMIR density only in the C1 region (P<.05). In the SRL, the correlation coefficient of the STMI/SMIR density in the TAO group was -0.538 (r = -0.538, P = .032), and visual acuity was -0.624 (r = -0.624, P = .010). Conclusion: OCTA findings suggest that active TAO patients present with an increased retinal MIR density. Moreover, increased macular STMI and SMIR density might affect visual acuity.
引用
收藏
页码:658 / 667
页数:10
相关论文
共 50 条
  • [21] The Diagnosis and Treatment of Thyroid-Associated Ophthalmopathy
    Gould, Daniel J.
    Roth, Forrest S.
    Soparkar, Charles N. S.
    AESTHETIC PLASTIC SURGERY, 2012, 36 (03) : 638 - 648
  • [22] AZATHIOPRINE IN THE TREATMENT OF THYROID-ASSOCIATED OPHTHALMOPATHY
    PERROS, P
    WEIGHTMAN, DR
    CROMBIE, AL
    KENDALLTAYLOR, P
    ACTA ENDOCRINOLOGICA, 1990, 122 (01): : 8 - 12
  • [23] 2021 update on thyroid-associated ophthalmopathy
    Neag, E. J.
    Smith, T. J.
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2022, 45 (02) : 235 - 259
  • [24] Animal models of thyroid-associated ophthalmopathy
    Ludgate, ME
    THYROID, 2002, 12 (03) : 205 - 208
  • [25] Medical treatment for thyroid-associated ophthalmopathy
    Perros, P
    Kendall-Taylor, P
    THYROID, 2002, 12 (03) : 241 - 244
  • [26] PATHOGENETIC MECHANISMS IN THYROID-ASSOCIATED OPHTHALMOPATHY
    PERROS, P
    KENDALLTAYLOR, P
    JOURNAL OF INTERNAL MEDICINE, 1992, 231 (03) : 205 - 211
  • [27] Current management of thyroid-associated ophthalmopathy
    Kendall-Taylor, P
    CLINICAL ENDOCRINOLOGY, 1998, 49 (01) : 11 - 12
  • [28] Teprotumumab for thyroid-associated ophthalmopathy OPTIC
    Gaertner, R.
    Nitschmann, S.
    INTERNIST, 2020, 61 (11): : 1208 - 1210
  • [29] Measurements of saccades in thyroid-associated ophthalmopathy
    Schworm, HD
    Buser, A
    Botzel, K
    Heufelder, AE
    Leikam, B
    Boergen, KP
    OPHTHALMOLOGE, 1997, 94 (03): : 211 - 216
  • [30] Retinal and peripapillary nerve fiber layer thickness in eyes with thyroid-associated ophthalmopathy
    Neudorfer, Meira
    Blum, Sharon
    Kesler, Anat
    Varssano, David
    Leibovitch, Igal
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2013, 54 (15)